Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 4 institutions in 1 country.
Chandrika SanapalaDepartment of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY.
Marielle Jensen-BattagliaDepartment of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY.ORCID 0000-0003-1941-9218
Marissa LoCastroDepartment of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY.ORCID 0000-0002-1075-8443
Ying WangDepartment of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY.
Eva CulakovaDepartment of Surgery, University of Rochester Medical Center, Rochester, NY.
Michael SohnDepartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-4981-8351
Marie FlannerySchool of Nursing, University of Rochester Medical Center, Rochester, NY.
Allison MagnusonDepartment of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY.ORCID 0000-0002-0968-8265
Tanya M WildesDivision of Hematology/Oncology, University of Nebraska Medical Center/Nebraska Medicine, Omaha, NE.
Kah Poh LohDepartment of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, NY.ORCID 0000-0002-6978-0418
University of Rochester Medical Center · USEmory University · USPrinceton University · USUniversity of Nebraska Medical Center · US
Funding
URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Mitigating Cancer-Related Cognitive Dysfunction in Older Adults with Breast CancerK76AG064394 · NIA · UNIVERSITY OF ROCHESTER · PI MAGNUSON, ALLISON MARIAN · 2019 to 2023
$1.3M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
Epigenetic markers, functional status, and exercise in older adults with myeloid neoplasmsR03AG073985 · NIA · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2022 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
In-person and virtual assessment of short physical performance battery test in older adults with myeloid malignancies. · full record | Socratic